Salistick, world’s first Saliva-based
pregnancy test is launched in the United Kingdom by Abingdon Health
United
Kingdom: On Tuesday,
20th June 2023, SaliStick, the world's first saliva-based pregnancy
test, was launched in the United Kingdom. The test claims to be able to detect
pregnancy with a simple "spit test”. This patented technology allows for
the sensitive detection of the pregnancy hormone hCG, which is produced after
the implantation of fertilized egg. Later, this pregnancy hormone travels from
blood to saliva, where it can be detected. Therefore, providing women with a
more convenient and hygienic way to test for pregnancy. In the United Kingdom,
there were 694,685 live births recorded in 2021, compared with 681,560 in the
previous year.
'Salistick', which is a
saliva-based pregnancy test kit was created by a Jerusalem-based startup
Salignostics Limited, this innovative solution is allowing women to conduct the
tests anytime, anywhere without going to the bathroom. This technology is
entirely based on the same technology that created COVID-19 testing kits. This saliva-based
pregnancy test is the most recent technique in the lengthy and peculiar history
of pregnancy divination. This revolutionary product can tell women if they are
pregnant from just their saliva. In order for the test to be effective, a woman
must place a foam-tipped stick from the kit in her mouth for a few seconds,
like a thermometer. This collects a sample of saliva, and later provides the
results.
The
launch of the new Salistick TM saliva pregnancy test in the UK is a significant
development in the field of pregnancy testing. Abingdon Health PLC has brought
this advanced testing solution to the market and are partnering with Superdrug,
a popular health and beauty retailer in the UK, for the launch of the Salistick
TM Saliva Pregnancy Test.
According to the Co-Founder of
Salignostics,
“Saliva is the key to rapid diagnostics for a variety of medical reasons. It is
the only non-invasive, easy, and hygienic means to detect hormones, viruses,
and even diseases. With SaliStick, we leverage the powerful diagnostics
abilities we have been able to create from analyzing saliva. This product
completely removes the need for blood and urine samples when testing for
pregnancy.” Further, Chief Executive Officer, the Abingdon Health, commented:
“This novel technology provides women with an enhanced user experience;
offering the ability to test anywhere, anytime, and for the testing experience
to be shared with a partner and other loved ones.”
According to TechSci Research, the launch of the Salistick
TM saliva pregnancy test in United Kingdom is a significant milestone for York
based Abingdon Health PLC, and Salignostics. The advent of Salistick TM
represents a pivotal moment in the evolution of pregnancy home-testing and will
help in the market expansion of both the companies. Also, this launch of
saliva-based pregnancy test in the United Kingdom has strengthened the
positioning of Abingdon Health PLC. Moreover, other companies that are developing
or launching saliva-based pregnancy tests should take advantage of this opportunity
by investing in research and development, partnering with healthcare providers,
and marketing their products to women. The introduction of SaliStick could lead
to increased competition in the pregnancy test market. This could drive down
prices and improve the quality of pregnancy tests overall. Also, it can open up
new market opportunities for companies that sell pregnancy tests. In addition,
the launch of SaliStick pregnancy test has made a positive impact on the
pregnancy detection kits market.